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It was with interest that I read the above paper. The
previous study by Rothwell et al.1 makes clear the sub-
groups of patients with symptomatic carotid stenosis
and who would benefit most and least from carotid
endarterectomy.
The conclusion by Naylor, Rothwell and Bell that
units should quote their own results for stroke/death at
30 days is extremely important. It is unjustified to apply
published results to other units unassociated with said
publications. Over the last two decades, most specialist
units have found a stroke/death risk in symptomatic
patients of approximately 2% validated by neurologists.
This comprises 0% ipsilateral stroke, but with MI death,
contralateral stroke and cerebral haemorrhage from
reperfusion, contributing to the overall 2%.
In the UK, with league tables now in fashion, it would
be useful for patients and doctors alike, if carotid
endarterectomies were publicly audited and published
as they were last year for aortic aneurysm repair.
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It was with interest that I read the above paper. The
previous study by Rothwell et al. makes clear the
subgroups of patients with symptomatic carotid
stenosis and who would benefit most and least from
carotid endarterectomy.
The conclusion by Naylor, Rothwell and Bell that
units should quote their own results for stroke/death at
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